NICOLE ALLEN: Open Payments
NPI 1881062289 · OWENSBORO, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,742 in 94 payments from 15 companies in 2025. Trend: 2023 $1,028 · 2024 $2,280 · 2025 $1,742
Food & beverage: $1,643Education: $99
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 34 | $471 |
| EMD Serono, Inc. | 10 | $243 |
| UCB, Inc. | 8 | $183 |
| Teva Pharmaceuticals USA, Inc. | 7 | $182 |
| Neurocrine BioSciences, Inc. | 8 | $179 |
| Novartis Pharmaceuticals Corporation | 13 | $176 |
| Alexion Pharmaceuticals, Inc. | 2 | $62 |
| Genentech USA, Inc. | 3 | $53 |
| Biogen, Inc. | 2 | $52 |
| Boston Scientific Corporation | 2 | $40 |
Products named: QULIPTA, INGREZZA, KESIMPTA, Briviact, BOTOX, UBRELVY, AUSTEDO XR, ULTOMIRIS.
Industry payments across KY — which companies pay providers there.
